Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
06/2004
06/17/2004WO2004050622A1 Method of processing of hydrogen for reductive acylation of nitro, azido and cyano arenes
06/17/2004WO2004050620A2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
06/17/2004WO2004037769A3 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant
06/17/2004WO2004035534A3 Novel compounds having a dopaminergic and/or serotoninergic activity
06/17/2004WO2004026811A3 Succinic acid semi-amides as anti-corrosives agents
06/17/2004US20040116526 Polymorphic forms of nateglinide
06/17/2004US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
06/17/2004US20040115162 Dermatological preparations
06/16/2004EP1428817A1 ACID AMIDE DERIVATIVES, PROCESS FOR PRODUCING THESE, AND PEST CONTROL AGENT CONTAINING THESE
06/16/2004EP1427705A2 Insecticidal diamides
06/16/2004EP1427694A1 Fluorine-containing compounds and polymers derived therefrom
06/16/2004EP1278885B1 Resolution of aminotetralins
06/16/2004EP0977725B1 New fatty acid derivatives
06/16/2004CN1504455A Perfluoroalkylanilins
06/16/2004CN1153762C Method for preparation of N[1-(2,4-dichlorophenyl)ethyl]-2-cyano-3, 3-dimethyl butane amide
06/16/2004CN1153568C Compounds active at a novel position on receptor-operated calcium channel useful for treatment of neurological disorders
06/15/2004US6750369 Substituted amino acids as erythropoietin mimetics
06/15/2004US6750368 From acetone cyanohydrin, sulphuric acid and sulfur trioxide in a multistep process
06/15/2004US6750244 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/15/2004US6750171 Synthesis of P-chiral bisphospholane ligands and their transition metal complexes for use as asymmetric hydrogenation catalysts
06/10/2004WO2004047743A2 1-aryl-2-hydroxyethyl amides as potassium channel openers
06/10/2004WO2004047738A2 Arylcyclopropylcarboxylic amides as potassium channel openers
06/10/2004WO2003084943A9 Terphenyl derivatives, preparation thereof, compositions containing same
06/10/2004US20040110965 Chiral ligand
06/10/2004US20040110839 Compounds and compositions for delivering active agents
06/10/2004US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
06/10/2004US20040110754 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders
06/10/2004US20040110753 Tyrosine derivatives
06/10/2004CA2839590A1 Functional fragrance precursor
06/10/2004CA2839576A1 Functional fragrance precursor
06/09/2004EP1426353A1 1,3-minus;GLYCERIDE COMPOUND HAVING TWO IODOPHENYL GROUPS
06/09/2004EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases
06/09/2004EP1019364B1 Inhibitors of protein tyrosine phosphatase
06/09/2004CN1503780A Process for producing N-formylamino acid and utilization thereof
06/09/2004CN1503774A Carboxylic acid derivative and thereof
06/09/2004CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
06/09/2004CN1152884C Production of optically active phospholanes
06/08/2004US6747170 Leuco dyes; molecule having at least two aromatic rings, two carboxyl groups, and either two amides or two esters; preservation stability
06/08/2004US6747164 Esteramines derived from an ethoxylated alcohol that has been carboxymethylated, then esterified with a tertiary hydroxyamine; amidoamines are from a fatty acid or a fatty acid methyl ester and a diamine; fungicide; insecticide
06/08/2004US6747149 Glucamine salts for treating hepatitis virus infections
06/08/2004US6747043 Alkoxy aryl β2 adrenergic receptor agonists
06/08/2004CA2099783C (2r, 3s)-.beta.-phenylisoserine and its salts, preparation and use
06/08/2004CA2091002C Taxane derivatives, their preparation and use in oncology
06/03/2004WO2004046162A2 Non-steroidal fxr agonists
06/03/2004WO2004046096A2 Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics
06/03/2004WO2004046091A2 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions
06/03/2004WO2004045597A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
06/03/2004WO2004002926A3 Purification of n,n-dimethylacetamide
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106788 asymmetric hydrogenation of a lactam-enamide; multi-step synthesis
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004US20040106593 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
06/03/2004US20040106576 Derivatives of venlafaxine and methods of preparing and using the same
06/03/2004US20040106151 support-bound moieties and activated supports; utility in solid phase or solution phase synthesis, biosynthesis, catalysis, purification, analysis, and identification and screening; each moiety and activated support includes activator and linker
06/03/2004DE10253331A1 Verwendung von trans-Pellitori als Aromastoff Using trans-Pellitori as a flavoring
06/03/2004CA2506232A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
06/02/2004EP1424322A1 Low molecular weight branched alkenyl succinic acid derivatives prepared from low molecular weight polyisobutene and unsaturated acidic reagents
06/02/2004EP1423356A2 Novel aminobenzoephenones
06/02/2004EP1091929B1 Secondary aspartic acid amide esters
06/02/2004CN1152035C Furylphosphines and organometallic complexes containing the same
06/02/2004CN1152033C Synthese of substitutd pyrazolopyrimidines
06/02/2004CN1152006C Biphenyl derivatives
06/02/2004CN1151836C Compounds and compositions for delivering active agents
06/01/2004US6743916 Reacting an acetylene compound in the presence of a titanium compound and grignard reagent to obtain organotitanium compound
06/01/2004US6743877 Electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
06/01/2004CA2240937C A process for the optical resolution of 3-(p-chlorophenyl)-glutaramide
05/2004
05/27/2004WO2004043907A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same
05/27/2004WO2004043906A2 Use of trans-pellitorin in the form of an aromatic substance
05/27/2004WO2004029019A3 Compounds for the treatment of alzheimer’s disease
05/27/2004WO2004011523A3 Novel phase change solvents
05/27/2004WO2002079137A9 Interleukin-1 and tumor necrosis factor-alpha modulators and their enantiomers, their synthesis and use
05/27/2004US20040102650 Reacting hexachloroacetone with solvent-suspended resin-bound triphenylphosphine, chlorinating retinoic acid to provide retinoyl chloride, then stirring in pyridine; chromatography; for induction of apoptosis in cancer cells
05/27/2004US20040102646 Method of resolving optical isomers of amino acid derivative
05/27/2004US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease
05/27/2004US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
05/27/2004US20040102490 Antilipemic agents, antidiabetic agents and treatment of obesity
05/27/2004US20040102418 Compounds for the treatment of inflammatory disorders
05/27/2004US20040102355 Quaternary surfactants
05/27/2004US20040102338 Liquid intermediates; easy handling; lube oil detergents and dispersants; pour point depressants; paper surface sizing agents
05/27/2004DE10252275A1 Perfluoralkylaniline Perfluoralkylaniline
05/27/2004DE10252273A1 Polyhalogenalkylaryle Polyhalogenalkylaryle
05/27/2004CA2503992A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same
05/26/2004EP1421927A1 Dental self-etching primer
05/26/2004EP1421069A1 Process for the preparation of cyclopenta[g]quinazoline derivatives
05/26/2004EP1421059A1 Process for the preparation of enantiomerically enriched n-acyl-beta-amino acid derivatives by enantioselective hydrogenation of the corresponding (z)-enamides
05/26/2004EP1421057A1 Chemotherapeutic agents
05/26/2004EP1066263B1 Novel cationic 2-acylaminophenols, their use as coupler for oxidation dyeing, compositions containing them, and dyeing methods
05/26/2004EP1015418B1 Denatonium capsaicinate and methods of producing the same
05/26/2004EP1005445B1 N-alkanoylphenylalanine derivatives
05/26/2004CN1499928A Alkylamine derivatives as antifouling agents
05/26/2004CN1498955A Thickener
05/26/2004CN1498881A Polyhalide alkaryl compound
05/25/2004US6740774 Reacting carboxamide with glyoxal monoacetal derivative
05/25/2004US6740758 Reacting p-anisidine with 3-chloropropionyl chloride in presence of sodium bicarbonate and toluene and cyclizing
05/25/2004US6740754 Process to produce oxazolidinones
05/25/2004US6740415 Powder paint binder composition
05/25/2004US6740253 From alkaline bromine byproduct solution obtained from bromine recovery plant, solution containing 25-35% bromine dissolved in aqueous lime or sodium hydroxide as alkali bromide and alkali bromate; replacement for liquid bromine
05/25/2004CA2081935C Anilide derivatives and their use for combating botrytis
05/21/2004WO2004041771A1 Compound protecting against ultraviolet
05/21/2004WO2004041211A2 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT